自2001年起，公司便为中国个人用户于数字平台上提供健康医疗服务。于2015年，公司亦开始为企业及机构提供企业服务及数字营销服务。在过去的20年里，公司一直参与中国健康及保健行业的重大数字化转型，促进公司的业务发展。Health Path (02587) was first listed. According to the announcement, each share was priced at HK$7.8, and a total of 25 million shares were issued, with 500 shares per lot, with a total proceeds of HK$0.195 billion. As of press release, it rose 27.56% to HK$9.95, with a turnover of HK$11.9178 million.
The Zhitong Finance App learned that Health Path (02587) was first listed. The announcement showed that each share was priced at HK$7.8, and a total of 25 million shares were issued, with 500 shares per lot, with a total proceeds of HK$0.195 billion. As of press release, it rose 27.56% to HK$9.95, with a turnover of HK$11.9178 million.
According to the prospectus, Health Path operates a digital health care service platform in China. According to Frost & Sullivan, the company is the fourth largest digital healthcare service platform based on the number of registered individual users on the platform as of December 31, 2023. According to Frost & Sullivan, based on 2023 revenue, Health Path is also the fifth largest digital healthcare service platform, with a market share of less than 5%.
Since 2001, the company has been providing healthcare services on digital platforms for individual users in China. In 2015, the company also began providing corporate services and digital marketing services to enterprises and organizations. Over the past 20 years, the company has been participating in the major digital transformation of China's health and healthcare industry to promote the company's business development.
